Pharmacy Services

The Health-Care M&A Meter: Hot 2018 to Be Followed by Hotter 2019– The outlook for health-care mergers and acquisitions in 2019 suggests even more transactions this year as compared to 2018, with activity in the hospital and health system sector expected to continue, as well as increasing volume of deals in the physician services, home health. and health-care IT sectors.

M&A activity in orthopedics, GI & more increased in Q4 — 6 numbers to know – Physician specialties such as gastroenterology, orthopedics and urology saw an uptick in private equity consolidation activity in the fourth quarter of 2018, according to Provident Healthcare Partners.

Health-Care Info Tech Companies Make Moves in November– Health-care information technology companies stole the deal spotlight in November, setting up end-of-year numbers rivaling those of the long-term care, physician practice, and health and hospital system sectors.

Q4-2018 Pharmacy Services Update – Consolidation activity within the pharmacy services space in 2018 was defined by a new wave of vertical integration. Cigna, Aetna, and UnitedHealth are using acquisition strategies to more actively engage patient populations, with the hopes of improving outcomes and managing costs.

16th Annual Healthcare and Life Sciences Private Equity and Finance Conference – Kevin Palamara is attending the conference taking place February 20-21 in Chicago. He will also be participating in the panel discussion “Key Opportunities and Issues in Ophthalmology Investments.”

2019 Health Care Services Private Equity Symposium – Scott Davis will be attending the symposium taking place March 6-7 in Miami.

17th Annual Investment and M&A Opportunities in HEALTHCARE: Investing in the Middle-Market Healthcare Sector – Justin Hand is attending the conference taking place March 18-19 in Marina del Ray.

15th Annual Specialty Pharmacy – Bill Bolding will be attending the 15th Annual Specialty Pharmacy Summit April 29- May 2 in Las Vegas.

Big Health System Deals Dominate Transactions in October-The announced merger of two major Texas health systems is October’s deal-of-the-month.

What to Expect in a Due Diligence Process – Episode 7 of Provident’s Healthcare Dealcast

Avella, Cardinal Specialty Pharmacy Are Focus of Deal – Michael Patton and Bill Bolding share some insight with AIS Health in Radar on Specialty Pharmacy.

What’s happening in the pharmacy space? Key thoughts from 2 Provident Healthcare leaders – Michael Patton and Bill Bolding sat down with Becker’s Hospital Review to share their thoughts on the recent trends in the pharmacy space.

INSIGHT: Long-Term Care Consolidations Lead Third Quarter Health Transactions – The breakneck pace of healthcare transactions continued unabated in the third quarter.

What are the key financial factors to focus on when undergoing a process?– Episode 6 of Provident’s Healthcare Dealcast

Q3-2018 Pharmacy Services Update – Two multi-billion dollar pharmacy services deals in the third quarter are signaling a heightened interest in pharmacy from both strategic consolidators and private equity investors.

Private Equity Investment in Health Care Stays Strong – Private equity investment is burgeoning throughout the U.S., and health care is one of the “in” targets for investors.

What is Private Equity?– Episode 4 of Provident’s Healthcare Dealcast

Health IT Sector Showing High Potential for Accelerated Growth – The health information technology sector is poised to become the next big thing for investors in the health-care industry. The physician practices sector experienced the second-highest growth in July, with an emphasis on certain medical practice areas.

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”